Page 26 - Syndipharma
P. 26

Premier partners:
          RESEARCH AND DEVELOPMENT
          The Most important facet of our overall operation.
          Comprised of a core of Ph.D. and M.Sc. chemists, Ds with supporting technical staff including chemical, mechanical
          and electrical  engineers.
          Close scientific ties with a number of major academic institutions including faculty membership and Ph.D. committee
          membership of Arasto’s senior research staff in major universities.
          In-house state-of-the-art equipment such as HPLCs, GCs, UV, IR Atomic Absorption, polarimeter, etc.
          Access to high-end analytical instruments such as high resolution 1H and 13C NMR, Mass Spec, Single Crystal and
          Powder X-Ray through major academic institutions.
          Over 40 US and 600 international process and product patents (multiple filings) granted to our scientists.http://www. IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
          freepatentsonline.com
          Numerous scholarly publications in high impact scientific journals.
          Development of novel formulations (non-infringing) for the reduction of GE side effects as well as improved patient
          compliance.
          Development of non-infringing process patents based on client’s specifications.


          Certificates:
          CURRENT GOOD MANUFACTURING PRACTICE
          Strict adherence to over 1000 comprehensive Standard Operating Procedures (SOPs).
          Strict adherence to cGMP guidelines as set by the FDA and the ICH and regulation of 21 CFR Part 211.
          Continuing in-house and off-site training of personnel on cGMP –related matters.

          Target Countries for Exports:
          • Afghanistan    • Syria    • Iraq      • Sri Lanka      • Vietnam       •Uganda

          Contact details:
          No. 8 ,23  st, yousefabad Jahanara Ave, Tehran, Iran
                 rd
          Postal code:1438933741
          Tel: +98-21-(88497347-88497344-88497340)
          Fax: +98-21-88497320
          E-mail: info@avicenna.ir
          export@avicenna.ir

        Product List

         Type     Product                  Strengh       Dosage form  Indication                Status


         Drug     Acetylcysteine (EFF)     600 mg        Tablet(EFF)  Mucolytic                 Available



         Drug     Aciclovir                200  &  400 mg  Tablet    Antiviral                  Available


         Drug     Aciclovir                800 mg        Tablet      Antiviral                  Available


         Drug     Alendronate              70 mg         Tablet      Bone resorption inhibitor  Available


         Drug     Amlodipine + Atorvastatin  5/20 mg     Tablet      Antianginal- antihyperlipidemic  Available

                  Avigrippe
         Drug     (Acetaminophen/Phenyleph-  650/10/4 mg  Tablet     Analgesic - decongestant- Antihis-  Available
                                                                     tamine
                  rine/ Chlorpheniramine)                                                                     25
                                                                you can find the rest of the product list on page 205
   21   22   23   24   25   26   27   28   29   30   31